Tripos Discovery Research Ltd. (TRPS), a Subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), Enters Agreement with CombinatoRx, Incorporated (CRXX) to Optimize Novel Compounds  
8/28/2007 10:46:42 AM

RICHMOND, Va. & BUDE, England--(BUSINESS WIRE)--Tripos Discovery Research Limited (TDR), a wholly owned subsidiary of Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ Capital Market:CBTE) and a leading provider of drug discovery chemistry services and small molecule products, announces today that it has entered into a service agreement with CombinatoRx, Incorporated (CombinatoRx) (NASDAQ:CRXX), a company specializing in the new field of synergistic combination pharmaceuticals.